Introduction
Bacteria produce an extraordinary array of small molecules, which formed the historical basis for much of chemistry and biology and later became the major discovery paradigm for the pharmaceutical industry. Defining their complex molecular structures prompted major advances in both analytical and synthetic chemistry, and understanding their biological functions led to the identification of their macromolecular targets and biological mechanisms. Together, these advances combined to create a greatly increased understanding of biological mechanisms and supply of therapeutic agents. The resulting aura surrounding naturally occurring molecules, which seem so different from their vastly more numerous relatives created in the laboratory, obscures the recognition that their most significant feature is their evolutionary history. They represent the current survivors of numerous and continuing rounds of modification, selection, and amplification on a limited set of starting materials with a modest set of chemical reactions. Ironically, while we know and continue to learn a great deal about the chemistry and biology of these molecules, we know relatively little about their evolutionary histories. What were the genetic mechanisms that led to the structures seen today? Several recent reports have begun to provide preliminary answers to these questions.
The antibiotic erythromycin, the anticancer agent bleomycin, the immunomodulator rapamycin, along with many other important molecules are produced by the sequential operation of enzymes, and the ordered sequence of conversions leading from a starting material to a final product is called a biosynthetic pathway. The enzymes that make up a pathway are, of course, genetically encoded, and in bacteria a pathway's genes are typically clustered on a contiguous stretch of DNA. This collection of genes is referred to as a biosynthetic gene cluster or BGC. How do BGCs evolve? Gradually accumulating changes in a lineage, a process familiar from animal and plant evolution, would be one possibility. The spatial organization of the genes that make up a typical BGC, however, shows hallmarks of recombination. A single BGC can often be divided into distinct subclusters, and each subcluster is defined by its own independent evolutionary history [1, 2] . A typical bacterial BGC is best described as an assembly of smaller parts that have both independent and co-evolutionary histories, and this summation model in which biosynthetic parts are mixed to create new molecules appears to be the path most often followed to create molecular diversity. High-quality genome sequences have increasingly confirmed that horizontal gene transfer (HGT) is the major contributor to the genetic diversity seen in bacteria [3] [4] [5] , and this extensive genetic exchange argues that modifications to BGCs are strongly dependent on the environment. In this minireview, we first compare two general evolutionary trajectories for the way in which small molecules originate and spread, and then we review recent observations that illustrate how HGT contributes to the catalogue of small molecules within specialized bacterial niches.
General Considerations for Biosynthetic Pathway Evolution
BGCs evolve in many different ways. Changes to the numbers or functions of their genes, the nucleotide sequences, genetic organization and context in which they appear all can have profound effects on the small-molecule products and the levels of their production. The major distinctions between the genes that encode a small molecule are reflected in the way it evolves. The most well-studied classes of small molecules are the ribosomally synthesized and post-translationally modified peptides (RiPPs), non-ribosomal peptides, and polyketides. As the name suggests, the precursors of RiPPs are genetically encoded by a single gene that is heavily modified by additional enzymes after translation [6] . In this case, evolution can occur rapidly at the single gene level to diversify or finely tune a chemical structure. One prominent example is the patellamide family of small molecules, which are produced by cyanobacterial symbionts of ascidians. A metagenomic survey of the patellamide family BGCs from sponge samples revealed that the large number of distinct small molecules that have been isolated result from a large number of naturally occurring genetic variants; however, the variation is confined to two regions within the single gene that encodes the precursor [7] . In contrast, the non-ribosomal peptides and polyketides are typically encoded by large clusters with a number of multi-modular enzymes that have evolved by gene-duplication and recombination events [2] . Notably, although each of these mechanisms contributes to the molecular innovations of a single organism, the whole bacterial ecosystem and the gene flow that exists between bacteria potentiate these evolutive mechanisms.
Genesis and Dissemination of Bacterially Produced Small Molecules
Naturally occurring small molecules vary markedly in their distribution. Some, like the amino acid tryptophan, can be found in all living organisms -either biosynthesized or acquired -while others have limited distribution. These limits also vary widely. Indole-3-acetic acid (IAA), best known as a plant auxin, is widespread in plants, fungi, and bacteria, whereas pyrrolnitrin, an antifungal agent, has been reported in Proteobacteria (Figure 1 ) [8] [9] [10] . Both IAA and pyrrolnitrin are generated from tryptophan. IAA is the product of at least five different bacterial biosynthetic pathways, indicating that the widespread distribution of this important molecule is due, in part, to convergent evolution [11] . Pyrrolnitrin production, in contrast, results from a single known four-gene operon [12] that is highly conserved [13] . An analysis of the distribution of the pyrrolnitrin (prn) operon argues for a single molecular origin that has spread in the environment through HGT [14] . This differential distribution undoubtedly reflects their differential biological functions. IAA is well known as a plant hormone, but it also plays roles in bacterial physiology [11, 15] . Pyrrolnitrin, by contrast, is only known as an antifungal antibiotic.
Additional features differentiate IAA and pyrrolonitrin. IAA's structure is remarkably similar to its starting material, tryptophan, and the enzymes that produce it are similar to enzymes involved in primary metabolism, catalyzing the same reactions on different substrates. As a result, the multiple independent pathways leading to IAA can evolve relatively easily by repurposing existing enzymes. In contrast, pyrrolnitrin's structure is a highly modified product of tryptophan, and some of the enzymes used in its creation are quite unusual, as highlighted by the incorporation of relatively rare chlorine atoms, a nitro functionality, and the destruction and creation of heterocyclic rings. Evolving these new enzymatic functions, in particular the heterocyclic ring chemistry, creates a high barrier for chemical innovation. This barrier leads to a limited distribution, which simplifies the documentation of the spread of a highly specialized pathway like that of pyrrolnitrin relative to the spread of the multiple convergent pathways like those of IAA. The innovation barrier is also evident from the high level of conservation of the BGC, which suggests that it is more likely that the genes that encode pyrrolnitrin have been, and will be, shared by HGT rather than be reinvented.
Both IAA and pyrrolnitrin have relatively small structures and correspondingly small BGCs for their production. In the growing catalogue of bacterially produced small molecules, most examples have significantly more complex structures and larger modular BGCs. Studying how these BGCs evolved clarifies past events and suggests tactics that could be useful for future endeavors. Early recognition of the modular nature of BGCs inspired the idea of a 'biosynthetic code' that could be harnessed to create new molecules through combinatorial biosynthesis [16] . Recently, synthetic biologists, operating with an expanded set of technologies and data, are revisiting the idea of deciphering and re-engineering or refactoring BGCs [17] . These efforts face many challenges, including the ability to find and predict compatible parts with which to increase diversity and expand biological function. It's likely that studying how Nature recombines modules will reveal important lessons for the application of synthetic biology to pathway engineering.
Lessons from Chemical Ecology
A focus on bacterially produced small molecules that are likely to be distributed by HGT simplifies studying the genetic changes involved in molecular innovation, and a focus on specialized bacterial populations in a defined environment provides a route to understanding the adaptive function of such innovation. A true understanding of an evolutionary history requires knowledge of both the method of distribution and the selection principles. Two recently discovered groups of Actinobacteria exemplify this analytical approach. One group is composed of the bacterial symbionts (genus Pseudonocardia) of fungus-growing ants and the second group is composed of bacteria from marine sediment (genus Salinispora). Both became prominent in the literature 15 years ago [18, 19] and are now among the best characterized genera of Actinobacteria. Studies of these genera have begun to address the challenge posed years ago by Carl R. Woese [20] : ''Our task now is to resynthesize biology; put the organism back into its environment; connect it again to its evolutionary past; and let us feel that complex flow that is organism, evolution and environment united.'' Pseudonocardia: Acquiring New Molecular Traits through Plasmid-encoded BGCs Bacteria adapt to their environments, and an individual's genetic make-up reflects this adaptation. These niche-adapted genes contribute to what is often referred to as the 'flexible genome' -the genes of an individual that are not generally found in a larger group of related bacteria. Plasmids encoding niche-adaptive small molecules are a particularly important example of the flexible genome.
Genome sequencing has repeatedly revealed that molecular diversity, not conservation, is the rule at the genus and even species levels. This diversity appears even within a highly specialized ecological niche. In the case of the ant-associated Pseudonocardia, the side-by-side growth of closely related bacterial isolates revealed antagonistic interactions [21] , and inoculation of laboratory-reared ants with distinct Pseudonocardia provided variable protection from a common fungal pathogen [22] . These phenomenological studies implicate both bacterially produced antibacterial and antifungal molecules and demonstrate that significant molecular diversity exists within this group of symbionts. The molecular and genetic bases of bacterial antagonism, perhaps more appropriately described as niche defense by one Pseudonocardia isolate against another, have recently been established [23] . A Pseudonocardia isolated from Apterostigma dentigerum living on the Barro Colorado Island in Panama was able to inhibit the growth of other closely related isolates from the same region. When compared to its closest relative, this Pseudonocardia differed only in plasmid content, and a single 119 kb plasmid contained the BGC for the antibacterial molecule 9-methoxyrebeccamycin ( Figure 2A) .
Additional plasmid-encoded traits appear to be widespread in the ant-associated Pseudonocardia. The BGC for the pseudonocardones [24] , a family of quinone-containing molecules, is located on an 850 kb megaplasmid, and the genes responsible for the production of the cyclic depsipeptides gerumycin A and B are encoded by a 297 kb plasmid [25] [26] [27] [28] . To date, all but one of the sequenced ant associates carry plasmids that encode BGCs. Although this is a small sample size, the frequency is (A) The plasmid-encoded rebeccamycin analogue was discovered through the investigation of intraspecies interactions. (B) The two BGCs reported for the gerumycins include a split biosynthetic pathway encoded by two plasmid-borne clusters and a unified version that was observed within a chromosomal genomic island. The blue and red boxes highlight the distinct plasmid-borne clusters that are unified on the chromosome, and the resulting molecule is colored to match the genes responsible for the product. The bright red genes denote mobile elements.
not uncommon for Actinobacteria, which have a relatively high occurrence of plasmid-borne BGCs. To provide a comparison, inspection of sequences available in the NCBI plasmid database using antiSMASH [29] shows that only 11% of the entries encode a BGC.
The previous examples illustrate that bacteria acquire plasmids from the environment to amass a larger pool of molecular diversity. Beyond the initial acquisition, the fates of these plasmids are largely unknown. The piperazic-acid-containing cyclic depsipeptides gerumycin A-C provide an interesting case study that addresses the mobility and enrichment of BGCs within an ecological niche ( Figure 2B ). The BGCs were encoded either on a plasmid or within a chromosomal genomic island in two different Pseudonocardia isolates. The difference in genetic context was not reflected in the shared gene content and nucleotide sequences which were conserved at 99% identity. The arrangement of the biosynthetic genes on the plasmid was particularly unusual in that they were not assembled at a single locus. Instead, two gene clusters, separated by 92 kb, encode the plasmid-borne gerumycins, and remarkably these two clusters were found adjacent to each other (as a single cluster) on the chromosomal genomic island. Overall, the example of the cyclic depsipeptides not only demonstrates the recruitment of a common molecular trait to organisms within an ecological niche but also highlights the importance of plasmids. The observation of two very distinct gene-cluster organizations shows the importance of genetic exchange and recombination in small-molecule evolution.
Split Clusters and BGC Evolution
The two-piece, or split, biosynthetic pathway for gerumycin both identifies a shortcoming in the conventional 'cluster' framework for the production of small molecules and provides further evidence for the mix-and-match logic of biosynthetic pathways. Gerumycin's split pathway is part of a small but growing catalogue of examples in which spatially separated and co-dependent genes or gene clusters have been reported for a single molecule. A biosynthetic strategy that is dependent on more than a single genetic locus is often referred to as BGC 'crosstalk' and appears to be relatively common for some molecular scaffolds, most notably siderophores (iron-binding small molecules). The hydroxamate siderophore erythrochelin produced by Saccharopolyspora erythraea, for example, is encoded by two loci, one for the core scaffold and one for a critical acetyltransferase [30] . Similarly, the genes required for the production and Current Biology 26, R859-R864, September 26, 2016 R861 Current Biology incorporation of 2,3-dihydroxybenzoate are often encoded just once within a bacterial genome despite possible incorporation into multiple natural products within a single organism. As another example, the production of the serratiochelins by Serratia plymuthica V4 relies on two BGCs, only one of which encodes the catechol [31] . Moreover, the siderophore rhodochelin from Rhodococcus jostii RHA1 uses three BGCs to generate a nonribosomal peptide scaffold that includes a 2,3-dihydroxybenzoic acid and two hydroxamates [32] . The range of molecules whose biosynthesis requires more than one pathway is unknown, but it is likely that the reports on this genetic strategy are underrepresented in the literature. Genome-mining efforts compensate for this deficiency. For example, the production of the glycosylated terpene sioxanthin from Salinispora tropica CNB-400 is dependent on four genetic loci [33] , and a single promiscuous enzyme is required for glycosylation during the biosynthesis of both a plecomacrolide and the methyl-rhamnosylated phenazines in Kitasatospora sp. MBT166 [34] . Finally, perhaps the most unusual example of this phenomenon is the reciprocally dependent BGCs in Streptomyces netropsis DSM40846 that encode a suite of at least three pyrrolamides [35, 36] . This all-for-one strategy, described as a natural example of combinatorial biosynthesis [36] , is a stark contrast to the one-for-all or diversity-generating biosynthetic pathways that have been dissected for decades, and it provides another confirmation of the summation model for assembling BGCs. Salinispora: Small Molecules Encoded on Genomic Islands While the ant-associated Pseudonocardia exploit a plasmidbased strategy for molecular acquisition, the small-molecule repertoire of Salinispora is primarily encoded within genomic islands [4, 5] -large stretches of DNA containing multiple genes and evidence of HGT. The documentation of these genomic islands reinforces some of the earliest observations made by studying the long-time model organisms of the Streptomyces spp. [3] . In Salinispora, fewer than 10% of the predicted BGCs are conserved between species or thought to be shared by the common ancestor of the genus [5] . The majority of the BGCs are encoded within conserved recombination hotspots (genomic islands) that are known to turn over gene content. In this regard, the Salinispora genomes are particularly enlightening, showing that the same genomic island can encode from one to five different BGCs depending on the individual, and that the identity of a BGC within a specific site can differ dramatically ( Figure 3A ) [5] .
The genetic exchange that populates and alters the content of these genomic islands in Salinispora also provides an example of how the process can result in the molecular diversification of a single class of small molecules ( Figure 3B ). The salinosporamides, a family of b-lactam-g-lactone-containing molecules produced by Salinispora pacifica and Salinispora tropica, are a particularly interesting example that correlates BGC mobility and molecular diversity. A direct comparison of the BGCs for salinosporamides A and K reveals the absence, in the BGC encoding salinosporamide K, of the biosynthetic genes for the chloroethylmalonyl-CoA required to produce salinosproamide A [37, 38] . In the minimal salinosporamide K clusters, a number of transposases surround key biosynthetic genes. Moreover, the alignment of high-quality sequences from a number of Salinispora species revealed that the genetic loci that encode the salinosporamides are not conserved between S. pacifica and S. tropica [5] . Interestingly, the observed Current Biology genetic change correlates with the pattern of molecular diversity in this family of small molecules that is most often manifested as a difference in the substituents appended on the g-lactam ring [39] . Altogether, the observed plasticity and turnover of BGCs in the Salinispora genomic islands further implicate HGT and recombination as major contributors to the natural history of small molecules, and the correlation between substituent and genetic diversity mirrors the bulk observation from sequencing data that subclusters are at least partially discrete evolutionary units.
Conclusions
This minireview reifies the long-standing microbial apothegm from Baas Becking: ''Everything is everywhere, but the environment selects.'' Plasmids, genomic islands, and HGT have long been recognized to play dominant roles in bacterial speciation, pathogenesis, and symbiosis [40, 41] . For example, a plasmid found in the bacterial symbionts of legume roots confers the ability to nodulate and fix nitrogen [42] and furthermore encodes a bacteriocin that likely contributes to the host organism's competitive fitness [43] . The latter is analogous to observations with the Pseudonocardia strains, which seem to rely largely on plasmids for chemical diversity and defense. The marine-sediment-dwelling Salinispora seem to rely more heavily on genomic islands for molecular diversification in a manner reminiscent of the virulence factors that characterize pathogenic bacteria. For example, pathogenic Escherichia coli and other Enterobacteriaceae can produce two small molecules associated with virulence and disease -the colibactins, which have DNA-damaging activity [44] , and yersiniabactin, a siderophore -both of which are encoded by BGCs located on a single genomic island [45] . Both plasmids and the contents of genomic islands are spread by HGT. The molecular repertoires of bacterial populations are in constant flux, changing under the influence of the local environment and microbial neighbors. As a collective, the microbial genomes in each environment provide raw materials, the genomic building blocks that individuals can mix and match to create the BGCs that provide selective advantages. Adding ecological considerations to genetic and molecular studies allows the selection principles to be identified and fills out a molecule's natural history, providing mechanistic insight into the manner in which BGCs are acquired and evolve.
